Ultrasound-guided Sciatic Nerve Block in Below Knee Amputation Surgery
Ultrasound -Guided Sciatic Nerve Block in Below Knee Amputation Surgery: Subgluteal Versus Popliteal
1 other identifier
interventional
56
0 countries
N/A
Brief Summary
56 ASA physical status II and III patients, aged 45-75 year, undergoing elective below knee amputation were randomly assigned to receive either sciatic nerve block using a popliteal approach or a sub gluteal approach. Patients in both groups received same amount of LA and additional ultrasound guided femoral nerve block to ensure sensory block of the medial side of the leg. Success of the block was considered when the block is solid and doesn't require shifting to GA
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 24, 2017
CompletedFirst Posted
Study publicly available on registry
January 9, 2018
CompletedJanuary 9, 2018
January 1, 2018
6 months
December 24, 2017
January 3, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
to compare between the two techniques as regards the success rate.
Success was considered when the block provided solid analgesia with no need to shift to GA
24 hours
Secondary Outcomes (1)
time taken to perform the block
10-20 min
Study Arms (2)
popliteal sciatic nerve block
ACTIVE COMPARATORinjecting 25 ml of bupivacaine 0.5 % (Sunnypivacaine, 20 ml vial contains Bupivacaine HCL Monohydrate 105.5 mg eq. to 100 mg Bupivacaine HCL, Sunny Pharmaceutical, Badr city- Cairo- Egypt) once circumferentially around the sciatic nerve at the popliteal fossa using ultrasound device (S-Nerve ultrasound system, Fujifilm Sonosite Inc., Bothell, WA)
subgluteal sciatic nerve block
ACTIVE COMPARATORinjecting 25 ml of bupivacaine 0.5 % (Sunnypivacaine, 20 ml vial contains Bupivacaine HCL Monohydrate 105.5 mg eq. to 100 mg Bupivacaine HCL, Sunny Pharmaceutical, Badr city- Cairo- Egypt) circumferentially around the sciatic nerve at the subgluteal region using ultrasound device (S-Nerve ultrasound system, Fujifilm Sonosite Inc., Bothell, WA).
Interventions
blocking sciatic nerve either at the subgluteal area or the popliteal region for effective anesthesia and analgesia during below knee amputation
Eligibility Criteria
You may qualify if:
- ASA physical status II and III patients
- aged 45-75 years,
- undergoing elective below knee amputation
You may not qualify if:
- patients who refused to participate in the study,
- those having allergy to local anaesthetics,
- or having contraindications to regional anaesthesia (having neurologic or neuromuscular disease, on anticoagulation therapy, or having skin infection at the site of needle insertion).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
December 24, 2017
First Posted
January 9, 2018
Study Start
January 1, 2017
Primary Completion
July 1, 2017
Study Completion
July 1, 2017
Last Updated
January 9, 2018
Record last verified: 2018-01